Ann Arbor company’s database licensed by AstraZeneca

Multi-national pharmaceutical company AstroZeneca has licensed a database created by Ann Arbor start-up Compendia Bioscience, Inc., created for cancer profiling.

Multi-national pharmaceutical company AstraZeneca International has licensed a database created by Ann Arbor start-up Compendia Bioscience, Inc., created for cancer profiling.


Excerpt:

Officials at Compendia Bioscience Inc.
of Ann Arbor said the recent deal with the $69 billion London-based drugmaker takes its product’s market penetration into 10 of the top 20 pharma companies in the world.

Read the entire article here.

THIS STORY FIRST APPEARED IN METROMODE

Author

Our Partners

30044
30045
30046
30047
30049
Washtenaw ISD logo
Eastern Michigan University
Ann Arbor Art Center
UMS
U of M Arts Initiative
Engage EMU

We want to know what's on your mind.

Close the CTA

Don't miss out!

Everything Ann Arbor and Ypsilanti, in your inbox every week.

Close the CTA

Already a subscriber? Enter your email to hide this popup in the future.